blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3694523

EP3694523 - METHODS AND SUBSTANCES FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  19.04.2024
Database last updated on 06.07.2024
FormerExamination is in progress
Status updated on  16.06.2023
FormerRequest for examination was made
Status updated on  17.07.2020
FormerThe international publication has been made
Status updated on  19.04.2019
Most recent event   Tooltip19.04.2024Application deemed to be withdrawnpublished on 22.05.2024  [2024/21]
Applicant(s)For all designated states
Locus IP Company, LLC
30600 Aurora Road Suite 180
Solon OH 44139 / US
[2020/41]
Former [2020/34]For all designated states
Locus IP Company, LLC
30500 Aurora Road, Suite 180
Solon, OH 44139 / US
Inventor(s)01 / FARMER, Sean
17230 NE 11th Avenue
North Miami Beach, FL 33162 / US
02 / ALIBEK, Ken
30500 Aurora Road
Suite 180
Solon, OH 44139 / US
03 / MOLDAKOZHAYEV, Alibek
30500 Aurora Road
Suite 180
Solon, OH 44139 / US
04 / TSKHAY, Albina
30500 Aurora Road
Suite 180
Solon, OH 44139 / US
 [2020/34]
Representative(s)Engelhard, Markus
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[2020/34]
Application number, filing date18867155.615.10.2018
[2020/34]
WO2018US55861
Priority number, dateUS201762572145P13.10.2017         Original published format: US 201762572145 P
[2020/34]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2019075456
Date:18.04.2019
Language:EN
[2019/16]
Type: A2 Application without search report 
No.:EP3694523
Date:19.08.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 18.04.2019 takes the place of the publication of the European patent application.
[2020/34]
Search report(s)International search report - published on:KR20.06.2019
(Supplementary) European search report - dispatched on:EP07.06.2021
ClassificationIPC:A61K31/70, A61K31/685, A61K45/06, A61K9/00, A61P25/28, A61K38/00, A61P25/16
[2021/27]
CPC:
A61K31/7048 (EP,US); A61K38/12 (EP); A61P25/16 (EP);
A61P25/28 (EP); A61K9/0053 (US)
Former IPC [2020/34]A61K31/70, A61K31/685, A61K45/06, A61K9/00, A61P25/28
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/34]
TitleGerman:METHODEN UND SUBSTANZEN ZUR PRÄVENTION UND BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN[2020/34]
English:METHODS AND SUBSTANCES FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES[2020/34]
French:MÉTHODES ET SUBSTANCES POUR LA PRÉVENTION ET LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES[2020/34]
Entry into regional phase27.04.2020National basic fee paid 
27.04.2020Search fee paid 
27.04.2020Designation fee(s) paid 
27.04.2020Examination fee paid 
Examination procedure27.04.2020Examination requested  [2020/34]
14.12.2021Amendment by applicant (claims and/or description)
16.06.2023Despatch of a communication from the examining division (Time limit: M06)
03.01.2024Application deemed to be withdrawn, date of legal effect  [2024/21]
23.01.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2024/21]
Fees paidRenewal fee
23.10.2020Renewal fee patent year 03
25.10.2021Renewal fee patent year 04
25.10.2022Renewal fee patent year 05
25.10.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]WO2008140262  (SEOUL NAT UNIV IND FOUNDATION [KR], et al) [X] 1,3-8 * example -; claim - * [Y] 1-13;
 [Y]US2012142621  (FALUS GEORGE [US], et al) [Y] 1-13 * paragraph [0007] *;
 [X]WO2017007099  (UNIV SEOUL NAT R & DB FOUND [KR]) [X] 1,3-8,10,11 * example -; claim - *;
 [XY]  - PARK SUN YOUNG ET AL, "Surfactin exhibits neuroprotective effects by inhibiting amyloid [beta]-mediated microglial activa", NEUROTOXICOLOGY, (20130529), vol. 38, doi:10.1016/J.NEURO.2013.07.004, ISSN 0161-813X, pages 115 - 123, XP028711076 [X] 1-7 * results, discussion * [Y] 1-13

DOI:   http://dx.doi.org/10.1016/j.neuro.2013.07.004
 [XY]  - PARK SUN YOUNG ET AL, "Involvement of PKA and HO-1 signaling in anti-inflammatory effects of surfactin in BV-2 microglial cells", TOXICOLOGY AND APPLIED PHARMACOLOGY, ACADEMIC PRESS, AMSTERDAM, NL, (20130127), vol. 268, no. 1, doi:10.1016/J.TAAP.2013.01.017, ISSN 0041-008X, pages 68 - 78, XP028994280 [X] 1-7 * results, discussion * [Y] 1-13

DOI:   http://dx.doi.org/10.1016/j.taap.2013.01.017
 [Y]  - ELENI ANDREADOU ET AL, "Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease", JOURNAL OF ALZHEIMER'S DISEASE, NL, (20170703), vol. 59, no. 1, doi:10.3233/JAD-161020, ISSN 1387-2877, pages 209 - 222, XP055617912 [Y] 1-13 * results, discussion *

DOI:   http://dx.doi.org/10.3233/JAD-161020
 [A]  - Marcos Roberto De Oliveira ET AL, "Review: Sophorolipids A Promising Biosurfactant and it's Applications", International Journal of Advanced Biotechnology and Research, (20150101), pages 161 - 174, URL: https://pdfs.semanticscholar.org/eccd/77e5f4d9b4a108c001c38c511746882fb09b.pdf, XP055562085 [A] 1-13 * paragraph [03.3] - paragraph [3.3.2] *
International search[X]US2010267684  (SEONG SEUNG-YONG [KR], et al) [X] 1, 4-18 * See claims 1, 15, 20. *;
 [X]US2012142621  (FALUS GEORGE [US], et al) [X] 1-18 * See paragraphs [0005], [0007]. *;
 [X]WO2016168197  (UNIV YALE [US]) [X] 1-18 * See claims 1, 15, 23, 25; page 3, lines 24-27, page 42, lines 7-8. *;
 [X]  - OLIVEIRA, M. R. et al., "Review: Sophorolipids a promising biosurfactant and it' s applications", International Journal of Advanced Biotechnology and Research, (20150000), vol. 6, no. 2, pages 161 - 174, XP055562085 [X] 1-18 * See the whole document. *
 [A]  - ANDREADOU, E. et al., "Rhamnolipids, microbial virulence factors, in Alzheimer's disease", Journal of Alzheimers Dissease, (20170703), vol. 59, no. 1, pages 209 - 222, XP055617912 [A] 1-18 * See the whole document. *

DOI:   http://dx.doi.org/10.3233/JAD-161020
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.